TheEdgeResearch
Home / Stocks / STVN

Stevanato Group S.p.A. (STVN)

NYSE Healthcare Medical - Instruments & Supplies
$15.65 ▼ -1.76%
Market Cap
$4.27B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
0.80
52-Wk Range
12.05-24.01
CEO
Franco Stevanato
Country
IT
Currency
USD

Stevanato Group S.p.A. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Piombino Dese, PD, IT. The stock last traded at $15.65, down 1.76% on the session, giving a market capitalisation of $4.27B. On trailing twelve-month figures it carries a trailing P/E of 27.98, a net margin of 11.2%. Its beta of 0.80 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
27.98
Price / Sales
3.14
Price / Book
2.44
EV / EBITDA
13.89
Gross margin
29.1%
Operating margin
16.2%
Net margin
11.2%
Return on equity
—
Debt / equity
0.29
Current ratio
1.73
Dividend yield
0.4%
Payout ratio
10.4%
Company profile
Exchange
New York Stock Exchange
Employees
6,010
IPO date
2021-07-16
Headquarters
Piombino Dese, PD, IT
About Stevanato Group S.p.A.

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Comparable companies

Stevanato Group S.p.A. is most often compared with the following Healthcare names:

ATRAVTRAXSMBLCOBTSGCHEMASIMMSINUVLTFX
More research on STVN
STVN technical analysis STVN TheEdge Score Compare against peers
Open full interactive analysis & DCF →